GlobeNewswire 10/11/2025 Vaxxas Appoints Veteran Vaccine Leader to Board as Company Advances Needle-Free Vaccine Patch Toward...
GlobeNewswire 10/11/2025 Cingulate Names Industry Veteran Bryan Downey Chief Commercial Officer to Lead Launch Preparation fo...
GlobeNewswire 10/11/2025 Nurix Therapeutics Appoints Accomplished Biopharmaceutical Leader Roger Dansey, M.D., to Its Board o...
GlobeNewswire 08/11/2025 Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Prese...
GlobeNewswire 07/11/2025 Nurix Therapeutics Presents New Translational Data from First-in-Human Clinical Trial of Oral CBL-B ...
GlobeNewswire 07/11/2025 Dupixent® (dupilumab) Pivotal Trial Met All Primary and Secondary Endpoints, Reducing Signs and Symp...
GlobeNewswire 07/11/2025 Press Release: ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary e...
GlobeNewswire 06/11/2025 Denali Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
GlobeNewswire 06/11/2025 Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer
GlobeNewswire 06/11/2025 Route 92 Medical Appoints Medtech Industry Leader Pat Mackin to its Board of Directors
GlobeNewswire 06/11/2025 Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance
GlobeNewswire 05/11/2025 Cytokinetics Reports Third Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire 05/11/2025 Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors
GlobeNewswire 05/11/2025 MoonLake Immunotherapeutics Reports Third Quarter 2025 Financial Results and Announces New Data from...
GlobeNewswire 05/11/2025 Teva's Innovative Portfolio Drives 11th Consecutive Quarter of Growth in Q3 2025; Increases 2025 Out...
GlobeNewswire 05/11/2025 Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire 04/11/2025 Vaxcyte Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Da...
GlobeNewswire 04/11/2025 Kymera Therapeutics Announces Third Quarter 2025 Financial Results and Provides a Business Update
GlobeNewswire 03/11/2025 Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual M...
GlobeNewswire 03/11/2025 Recludix Pharma to Present at Two Investor Conferences in November
GlobeNewswire 03/11/2025 Kailera Therapeutics Appoints Frank Clyburn to Board of Directors
GlobeNewswire 03/11/2025 Draig Therapeutics Appoints Seasoned Neuroscience Leader Ivana Magovčević-Liebisch as President and ...
GlobeNewswire 31/10/2025 Dupixent® (dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechnology Product Award
GlobeNewswire 30/10/2025 Nurix Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire 29/10/2025 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 20...